重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000950 重药控股

已收盘 12-19 15:00:00

{"stockData":{"symbol":"000950","market":"SZ","secType":"STK","nameCN":"重药控股","latestPrice":6.06,"timestamp":1734591828000,"preClose":6.17,"halted":0,"volume":48103031,"delay":0,"floatShares":1728000000,"shares":1728000000,"eps":0.2486,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.11,"latestTime":"12-19 15:00:00","open":6.18,"high":6.22,"low":5.88,"amount":289000000,"amplitude":0.0551,"askPrice":6.06,"askSize":716,"bidPrice":6.05,"bidSize":951,"shortable":0,"etf":0,"ttmEps":0.2486,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"adjPreClose":6.17,"symbolType":"stock","openAndCloseTimeList":[[1734571800000,1734579000000],[1734584400000,1734591600000]],"highLimit":6.79,"lowLimit":5.55,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1728184696,"pbRate":0.93,"roa":"--","roe":"2.57%","epsLYR":0.38,"committee":0.047439,"marketValue":10473000000,"floatMarketCap":10473000000,"peRate":24.376508,"changeRate":-0.0178,"turnoverRate":0.0278,"status":1},"requestUrl":"/m/hq/s/000950","defaultTab":"news","newsList":[{"id":"2490858217","title":"重药控股：12月11日接受机构调研，诚旸投资参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2490858217","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490858217?lang=zh_cn&edition=full","pubTime":"2024-12-11 19:33","pubTimestamp":1733916822,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年12月11日重药控股发布公告称公司于2024年12月11日接受机构调研，诚旸投资参与。重药控股2024年三季报显示，公司主营收入596.93亿元，同比上升2.24%；归母净利润2.92亿元，同比下降43.54%；扣非净利润2.77亿元，同比下降40.86%；其中2024年第三季度，公司单季度主营收入199.13亿元，同比上升12.7%；单季度归母净利润5413.7万元，同比上升1269.44%；单季度扣非净利润5879.22万元，同比上升1342.83%；负债率76.6%，投资收益2.42亿元，财务费用8.14亿元，毛利率7.44%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121100033217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"gpt_icon":0},{"id":"2490187072","title":"重药控股（000950）12月10日主力资金净卖出1355.31万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490187072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490187072?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:19","pubTimestamp":1733879974,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月10日收盘，重药控股报收于5.81元，下跌1.86%，换手率2.03%，成交量35.14万手，成交额2.08亿元。近5日资金流向一览见下表：重药控股融资融券信息显示，融资方面，当日融资买入3699.44万元，融资偿还4537.43万元，融资净偿还837.99万元。重药控股主营业务：主营业务为医药商业板块,涵盖药品、医疗器械、中药饮片、保健产品的医院纯销、商业批发、零售连锁、终端配送、仓储物流及供应链增值服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121100008701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"gpt_icon":0},{"id":"2490062179","title":"重药控股(000950.SZ)：重庆医药应收账款3期资产支持专项计划成功设立","url":"https://stock-news.laohu8.com/highlight/detail?id=2490062179","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490062179?lang=zh_cn&edition=full","pubTime":"2024-12-10 17:37","pubTimestamp":1733823465,"startTime":"0","endTime":"0","summary":"智通财经APP讯，重药控股(000950.SZ)公告，公司控股子公司重庆医药(集团)股份有限公司“重庆医药应收账款3期资产支持专项计划”于2024年12月10日设立，募集资金已于2024年12月10日到账，总规模达5亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000950","BK0071","BK0250"],"gpt_icon":0},{"id":"2485239156","title":"重药控股(000950)10月31日股东户数3.98万户，较上期增加3.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485239156","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485239156?lang=zh_cn&edition=full","pubTime":"2024-11-22 17:12","pubTimestamp":1732266754,"startTime":"0","endTime":"0","summary":"证券之星消息，近日重药控股披露，截至2024年10月31日公司股东户数为3.98万户，较9月30日增加1455.0户，增幅为3.79%。在医药商业行业个股中，重药控股股东户数高于行业平均水平，截至10月31日，医药商业行业平均股东户数为3.96万户。从股价来看，2024年9月30日至2024年10月31日，重药控股区间跌幅为4.69%，在此期间股东户数增加1455.0户，增幅为3.79%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200027914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"gpt_icon":0},{"id":"2482041202","title":"重药控股(000950.SZ)前三季度每10股派0.3元 股权登记日为11月15日","url":"https://stock-news.laohu8.com/highlight/detail?id=2482041202","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482041202?lang=zh_cn&edition=full","pubTime":"2024-11-11 19:30","pubTimestamp":1731324632,"startTime":"0","endTime":"0","summary":"智通财经APP讯，重药控股(000950.SZ)发布公告，公司将实施2024年前三季度权益分派，每10股派发0.3元现金(含税)，股权登记日为11月15日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000950","BK0071","BK0250"],"gpt_icon":0},{"id":"2480370268","title":"重药控股：关于证券事务代表辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2480370268","media":"新浪财经-鹰眼工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480370268?lang=zh_cn&edition=full","pubTime":"2024-11-04 18:20","pubTimestamp":1730715600,"startTime":"0","endTime":"0","summary":"重药控股股份有限公司关于证券事务代表辞职的公告重药控股股份有限公司董事会于2024年11月4日收到公司证券事务代表曹芳女士的书面辞职报告。其辞职不会影响公司相关工作的正常运作，曹芳女士的辞职报告自送达董事会时生效。截至本公告披露日，曹芳女士未持有公司股份。公司及董事会对曹芳女士任职期间为公司做出的贡献表示衷心感谢。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-04/doc-incuwwwc2148320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000950","161027","BK0071","BK0250"],"gpt_icon":0},{"id":"2480377615","title":"重药控股最新公告：证券事务代表曹芳辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2480377615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480377615?lang=zh_cn&edition=full","pubTime":"2024-11-04 18:11","pubTimestamp":1730715061,"startTime":"0","endTime":"0","summary":"重药控股公告，公司董事会于2024年11月4日收到公司证券事务代表曹芳的书面辞职报告。曹芳因工作调动原因，申请辞去公司证券部（董事会办公室）部长（主任）以及公司证券事务代表职务，辞职后不再担任公司及子公司任何职务。其辞职不会影响公司相关工作的正常运作。截至本公告披露日，曹芳未持有公司股份。公司及董事会对曹芳任职期间为公司做出的贡献表示衷心感谢。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400025260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","161027","000950"],"gpt_icon":0},{"id":"2480178193","title":"重药控股（000950）11月1日主力资金净买入184.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480178193","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480178193?lang=zh_cn&edition=full","pubTime":"2024-11-04 09:18","pubTimestamp":1730683107,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月1日收盘，重药控股报收于5.54元，上涨0.91%，换手率2.26%，成交量39.02万手，成交额2.15亿元。近5日资金流向一览见下表：重药控股融资融券信息显示，融资方面，当日融资买入4239.33万元，融资偿还2855.66万元，融资净买入1383.68万元，连续3日净买入累计2257.05万元。重药控股主营业务：主营业务为医药商业板块,涵盖药品、医疗器械、中药饮片、保健产品的医院纯销、商业批发、零售连锁、终端配送、仓储物流及供应链增值服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400002434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"gpt_icon":0},{"id":"2479020869","title":"重药控股：10月30日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2479020869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479020869?lang=zh_cn&edition=full","pubTime":"2024-10-30 19:08","pubTimestamp":1730286485,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年10月30日重药控股发布公告称公司于2024年10月30日召开业绩说明会。重药控股2024年三季报显示，公司主营收入596.93亿元，同比上升2.24%；归母净利润2.92亿元，同比下降43.54%；扣非净利润2.77亿元，同比下降40.86%；其中2024年第三季度，公司单季度主营收入199.13亿元，同比上升12.7%；单季度归母净利润5413.7万元，同比上升1269.44%；单季度扣非净利润5879.22万元，同比上升1342.83%；负债率76.6%，投资收益2.42亿元，财务费用8.14亿元，毛利率7.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000036889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"gpt_icon":0},{"id":"2478685998","title":"重药控股（000950）2024年三季报简析：增收不增利，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2478685998","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478685998?lang=zh_cn&edition=full","pubTime":"2024-10-26 06:10","pubTimestamp":1729894207,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期重药控股发布2024年三季报。截至本报告期末，公司营业总收入596.93亿元，同比上升2.24%，归母净利润2.92亿元，同比下降43.54%。按单季度数据看，第三季度营业总收入199.13亿元，同比上升12.7%，第三季度归母净利润5413.7万元，同比上升1269.44%。本报告期重药控股盈利能力上升，毛利率同比增幅2.09%，净利率同比增幅29.96%。本次财报公布的各项数据指标表现一般。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102600004473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"gpt_icon":0},{"id":"2477505543","title":"重药控股(000950)9月30日股东户数3.84万户，较上期减少1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477505543","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477505543?lang=zh_cn&edition=full","pubTime":"2024-10-24 17:03","pubTimestamp":1729760633,"startTime":"0","endTime":"0","summary":"证券之星消息，近日重药控股披露，截至2024年9月30日公司股东户数为3.84万户，较8月30日减少418.0户，减幅为1.08%。在医药商业行业个股中，重药控股股东户数高于行业平均水平，截至9月30日，医药商业行业平均股东户数为3.8万户。从股价来看，2024年8月30日至2024年9月30日，重药控股区间涨幅为19.25%，在此期间股东户数减少418.0户，减幅为1.08%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400028080.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"gpt_icon":0},{"id":"2477503697","title":"图解重药控股三季报：第三季度单季净利润同比增1269.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477503697","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477503697?lang=zh_cn&edition=full","pubTime":"2024-10-24 16:54","pubTimestamp":1729760078,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股2024年三季报显示，公司主营收入596.93亿元，同比上升2.24%；归母净利润2.92亿元，同比下降43.54%；扣非净利润2.77亿元，同比下降40.86%；其中2024年第三季度，公司单季度主营收入199.13亿元，同比上升12.7%；单季度归母净利润5413.7万元，同比上升1269.44%；单季度扣非净利润5879.22万元，同比上升1342.83%；负债率76.6%，投资收益2.42亿元，财务费用8.14亿元，毛利率7.44%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102400026971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950"],"gpt_icon":0},{"id":"2477577747","title":"重药控股(000950.SZ)发布前三季度业绩，净利润2.92亿元，同比下降43.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477577747","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477577747?lang=zh_cn&edition=full","pubTime":"2024-10-24 16:26","pubTimestamp":1729758401,"startTime":"0","endTime":"0","summary":"智通财经APP讯，重药控股(000950.SZ)发布2024年三季度报告，前三季度，公司实现营业收入596.93亿元，同比增长2.24%。归属于上市公司股东的净利润2.92亿元，同比下降43.54%。归属于上市公司股东的扣除非经常性损益的净利润2.77亿元，同比下降40.86%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000950"],"gpt_icon":0},{"id":"2474237763","title":"重药控股（000950）10月8日主力资金净卖出5287.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474237763","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474237763?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:25","pubTimestamp":1728437149,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月8日收盘，重药控股报收于5.84元，上涨1.39%，换手率4.7%，成交量81.31万手，成交额4.82亿元。近5日资金流向一览见下表：重药控股融资融券信息显示，融资方面，当日融资买入8845.74万元，融资偿还7578.05万元，融资净买入1267.69万元。重药控股主营业务：主营业务为医药商业板块,涵盖药品、医疗器械、中药饮片、保健产品的医院纯销、商业批发、零售连锁、终端配送、仓储物流及供应链增值服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900005828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0250","BK0071"],"gpt_icon":0},{"id":"2469118719","title":"重药控股最新公告：重药股份拟注册发行不超20亿元永续债","url":"https://stock-news.laohu8.com/highlight/detail?id=2469118719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469118719?lang=zh_cn&edition=full","pubTime":"2024-09-23 20:00","pubTimestamp":1727092857,"startTime":"0","endTime":"0","summary":"重药控股公告，控股子公司重药股份拟注册发行永续债，注册发行规模不超过20亿元（含）。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092300026606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"gpt_icon":0},{"id":"2467338310","title":"重药控股：9月13日接受机构调研，招银理财参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2467338310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467338310?lang=zh_cn&edition=full","pubTime":"2024-09-14 06:40","pubTimestamp":1726267240,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年9月13日重药控股发布公告称公司于2024年9月13日接受机构调研，招银理财参与。重药控股2024年中报显示，公司主营收入397.79亿元，同比下降2.3%；归母净利润2.38亿元，同比下降53.65%；扣非净利润2.19亿元，同比下降53.86%；其中2024年第二季度，公司单季度主营收入201.55亿元，同比下降4.46%；单季度归母净利润1.35亿元，同比下降61.13%；单季度扣非净利润1.26亿元，同比下降61.17%；负债率76.28%，投资收益1.64亿元，财务费用5.45亿元，毛利率7.77%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091400005517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"gpt_icon":0},{"id":"2466222535","title":"重药控股：截至目前公司的间接控股股东仍是重庆化医，本次调研为日常经营工作调研","url":"https://stock-news.laohu8.com/highlight/detail?id=2466222535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466222535?lang=zh_cn&edition=full","pubTime":"2024-09-12 17:02","pubTimestamp":1726131763,"startTime":"0","endTime":"0","summary":"公司控股股东正在进行的股权变化将导致公司间接控股股东发生变化，作为公司（原）间接控股股东董事长黄宗山在此敏感时期到公司调研并对公司未来提出具体意见，是否合适？是否意味公司控股股东战略整合的计划已经停止，公司间接控股股东仍将是重庆化医？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091200027143.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"gpt_icon":0},{"id":"2464882899","title":"重药控股：截至2024年8月30日，公司股东总户数为38,794户","url":"https://stock-news.laohu8.com/highlight/detail?id=2464882899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464882899?lang=zh_cn&edition=full","pubTime":"2024-09-02 18:04","pubTimestamp":1725271455,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)09月02日在投资者关系平台上答复投资者关心的问题。投资者：请问截止8月31日收盘公司股东人数多少?谢谢！重药控股董秘：截至2024年8月30日，公司股东总户数为38,794户。感谢您的关注！以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090200025602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"gpt_icon":0},{"id":"2463781257","title":"重药控股：截至2024年7月31日，公司股东总户数为39,919户","url":"https://stock-news.laohu8.com/highlight/detail?id=2463781257","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463781257?lang=zh_cn&edition=full","pubTime":"2024-08-30 18:05","pubTimestamp":1725012329,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)08月30日在投资者关系平台上答复投资者关心的问题。投资者：请问截止8月30日收盘公司在册股东人数多少?谢谢！重药控股董秘：截至2024年7月31日，公司股东总户数为39,919户。感谢您的关注！以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000036231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"gpt_icon":0},{"id":"2462486840","title":"华安证券：给予重药控股买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2462486840","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462486840?lang=zh_cn&edition=full","pubTime":"2024-08-28 14:55","pubTimestamp":1724828125,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,李昌幸近期对重药控股进行研究并发布了研究报告《上半年业绩承压，国企改革持续推进中》，本报告对重药控股给出买入评级，当前股价为4.64元。麻精药品板块营业收入为14.58亿元，同比增长3.85%，公司是全国性麻精药品第二大批发商，销售网络覆盖全国31个省市。根据中国医药公告显示本次整合或将导致重庆医药的控股股东和实际控制人变更为通用技术集团。维持“买入”投资评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800022107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","600909"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1999-09-16","address":"重庆市渝北区金石大道303号","stockEarnings":[{"period":"1week","weight":-0.0162},{"period":"1month","weight":0.0669},{"period":"3month","weight":0.2993},{"period":"6month","weight":0.1585},{"period":"1year","weight":0.2372},{"period":"ytd","weight":0.2372}],"companyName":"重药控股股份有限公司","boardCode":"AI0051","perCapita":"43387股","boardName":"批发业","registeredCapital":"172818万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":"　　重药控股股份有限公司主要从事医药商业、仓储物流、医药工业和研发等业务。公司的主要产品为药品、医疗器械等。公司在重庆市内区县入围40个联合体，全市医疗机构覆盖率居领先地位。公司是是中国三家经营特殊药品的全国性批发企业之一。","serverTime":1734651470762,"listedPrice":4.63,"stockholders":"39831人(较上一季度增加3.79%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"重药控股,000950,重药控股股票,重药控股股票老虎,重药控股股票老虎国际,重药控股行情,重药控股股票行情,重药控股股价,重药控股股市,重药控股股票价格,重药控股股票交易,重药控股股票购买,重药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}